Status:
COMPLETED
Bone Mineral Density and Subsequent Cancer Risk
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Endometrial Cancer
Breast Cancer
Eligibility:
FEMALE
55-80 years
Brief Summary
Recent cohort studies demonstrated reduced breast cancer risks among women with a history of fractures or low bone mineral density (BMD). In the Study of Osteoporotic Fractures, each standard deviatio...
Detailed Description
Recent cohort studies demonstrated reduced breast cancer risks among women with a history of fractures or low bone mineral density (BMD). In the Study of Osteoporotic Fractures, each standard deviatio...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Women previously enrolled in FIT and provided informed consent.
Exclusion
Key Trial Info
Start Date :
April 7 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 26 2020
Estimated Enrollment :
15595 Patients enrolled
Trial Details
Trial ID
NCT00340262
Start Date
April 7 2000
End Date
March 26 2020
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892